BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8953592)

  • 1. The NCCN Guidelines Development Program.
    Winn RJ; Botnick W; Dozier N
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):23-8. PubMed ID: 8953592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NCCN guideline program--1998.
    Winn RJ; Botnick WZ; Brown NH
    Oncology (Williston Park); 1998 Nov; 12(11A):30-4. PubMed ID: 10028501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NCCN Guideline Program: a conceptual framework.
    Winn RJ; Botnick WZ
    Oncology (Williston Park); 1997 Nov; 11(11A):25-32. PubMed ID: 9430176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NCCN and ACS collaborate on a patient's version of the NCCN practice guidelines for breast cancer. National Comprehensive Cancer Network. American Cancer Society.
    Rose VL
    Am Fam Physician; 1999 Nov; 60(7):2169-70. PubMed ID: 10569514
    [No Abstract]   [Full Text] [Related]  

  • 5. The NCCN/American Cancer Society partnership.
    McGivney WT; McGinnis L; Gansler TS;
    Oncology (Williston Park); 2000 Nov; 14(11A):213-6. PubMed ID: 11195412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The legal ramifications of the NCCN practice guidelines.
    Miller FH
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):35-9. PubMed ID: 8953594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Institutional validation of breast cancer treatment guidelines.
    Minter RM; Spengler KK; Topping DP; Flug R; Copeland EM; Lind DS
    J Surg Res; 2001 Sep; 100(1):106-9. PubMed ID: 11516212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roundtable discussion: Incorporating bone marrow transplantation into NCCN guidelines.
    Vaughan WP; Silver SM; Beatty PG; Tallman MS
    Oncology (Williston Park); 1998 Nov; 12(11A):390-2. PubMed ID: 10028522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The NCCN guidelines development process and infrastructure.
    Winn RJ;
    Oncology (Williston Park); 2000 Nov; 14(11A):26-30. PubMed ID: 11195417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline institutional compliance with NCCN guidelines: non-small-cell lung cancer.
    Walsh GL; Winn RJ
    Oncology (Williston Park); 1997 Nov; 11(11A):161-70. PubMed ID: 9430187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of preliminary NCCN guidelines by external review.
    Winn RJ; Botnick W; Bitsura JA
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):311-5. PubMed ID: 8953611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Panel discussion. Data needs in cancer.
    McGivney WT; Barker ML; Bost JE; Burns J; Loeb JM; Morris M; Roglieri JL; Stovall E; Swan DE
    Oncology (Williston Park); 1998 Nov; 12(11A):147-56. PubMed ID: 10028508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practice guidelines: patients' perspective.
    Stovall EL
    Oncology (Williston Park); 1996 Nov; 10(11 Suppl):255-60. PubMed ID: 8953608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nurses' guide to understanding and implementing the National Comprehensive Cancer Network guidelines for myeloid growth factors.
    Wilson BJ; Gardner AE
    Oncol Nurs Forum; 2007 Mar; 34(2):347-53. PubMed ID: 17573299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using tumor registry resources in analyzing concordance with guidelines and outcomes.
    Bookman MA
    Oncology (Williston Park); 2000 Nov; 14(11A):104-7. PubMed ID: 11195403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice guidelines. The Agency for Health Care Policy and Research fosters the development of evidence-based guidelines.
    McCormick KA; Fleming B
    Health Prog; 1992 Dec; 73(10):30-4. PubMed ID: 10122521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCCN breast cancer clinical practice guidelines in oncology: an update.
    Carlson RW
    J Natl Compr Canc Netw; 2003 Jan; 1 Suppl 1():S61-3. PubMed ID: 19795577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NCCN practice guidelines. Screening for and evaluation of suspicious breast lesions. National Comprehensive Cancer Network.
    Oncology (Williston Park); 1998 Nov; 12(11A):89-138. PubMed ID: 10028505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of guidelines. A comparison of the NCCN and ASCO lung cancer guidelines.
    Winn RJ; Brown NH; Botnick WZ
    Oncology (Williston Park); 1999 May; 13(5A):35-9. PubMed ID: 10370920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evidence-based management of neutropenia and fever].
    Ishiguro H; Fung MC; Sakata T; Morizane T; Adachi S
    Gan To Kagaku Ryoho; 2003 Sep; 30(9):1365-71. PubMed ID: 14518423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.